Continuia Pulse is Remote Patient Monitoring software sold to medical practices as a monthly subscription. Patients get monitored between visits; practices get reimbursed by Medicare and insurers for doing it, documented correctly, which is where most platforms in this space fail.
Remote monitoring reimbursement is an existing, government-funded program, not a new insurance product to convince anyone of. Practices bill under their own provider number and keep the reimbursement; Pulse is the software that lets them deliver the service and prove it happened.
Blood pressure, glucose, and weight readings; behavioral health check-ins; medication adherence tracking: one patient record, one platform, rather than switching software as a practice adds monitoring services.
The most common complaint across competing platforms: broken or unusable reporting that leaves practices unable to prove they did the work required to get paid. This is the specific gap Pulse is built to close.
A deliberately conservative amount of AI: reducing false alarms so clinical staff aren't drowning in noise, nothing that plays doctor. This is a liability-sensitive space, and Pulse is built to be trusted over flashy.
Primary care and cardiology practices with diabetic, hypertensive, or heart-failure patients: the clearest, least-disputed reimbursement path today, and the initial go-to-market focus.
A real, live product with pilot and paying practice customers. This is regulated, revenue-generating infrastructure in production, not a demo.
Pulse is a Continuia product, not a continuous.engineering consulting deliverable. Ask Maya which conditions and payers your practice is likely to qualify under, or open the app directly.